$180 Million is the total value of Cavalier Investments, LLC's 147 reported holdings in Q2 2017. The portfolio turnover from Q1 2017 to Q2 2017 was 57.1% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
XLV | Sell | Select Sector Spdretf | $10,093,000 | +5.0% | 127,355 | -1.5% | 5.62% | +4.4% |
XLB | Sell | Select Sector Spdretf | $8,898,000 | +2.3% | 165,359 | -0.4% | 4.95% | +1.7% |
XLF | Sell | Select Sector Spdretf | $8,729,000 | -9.2% | 353,828 | -12.7% | 4.86% | -9.8% |
AMAT | Sell | Applied Materials Inc. | $875,000 | -32.1% | 22,500 | -32.0% | 0.49% | -32.5% |
TTP | Sell | Tortoise Pipeline | $489,000 | -23.2% | 25,174 | -16.6% | 0.27% | -23.8% |
CHKP | Sell | Check Point Sftwre | $255,000 | -14.1% | 2,340 | -19.0% | 0.14% | -14.5% |
TOL | Sell | Toll Brothers, Inc. | $254,000 | -11.2% | 6,419 | -18.9% | 0.14% | -11.9% |
CELG | Sell | Celgene Corporation | $227,000 | -14.7% | 1,749 | -18.1% | 0.13% | -15.4% |
ICLR | Sell | Icon | $201,000 | -9.5% | 2,060 | -25.9% | 0.11% | -9.7% |
EXPGY | Exit | Experian | $0 | – | -9,825 | -100.0% | -0.11% | – |
BIIB | Exit | Biogen Inc | $0 | – | -735 | -100.0% | -0.11% | – |
MBBYF | Exit | Mobileye NVord | $0 | – | -3,480 | -100.0% | -0.12% | – |
AKAM | Exit | Akamai Technologies, Inc. | $0 | – | -3,863 | -100.0% | -0.13% | – |
PYPL | Exit | Paypal Holdings Incorporation | $0 | – | -5,545 | -100.0% | -0.13% | – |
MSCI | Exit | MSCI Inc. | $0 | – | -2,629 | -100.0% | -0.14% | – |
PNRA | Exit | Panera Bread Co | $0 | – | -1,013 | -100.0% | -0.15% | – |
XRAY | Exit | DENTSPLY SIRONA INC | $0 | – | -4,322 | -100.0% | -0.15% | – |
RYAAY | Exit | Ryanair LTDadr | $0 | – | -3,373 | -100.0% | -0.16% | – |
QRVO | Exit | Qorvo Inc | $0 | – | -4,895 | -100.0% | -0.19% | – |
VRP | Exit | Powershares Xtf Iietf | $0 | – | -31,035 | -100.0% | -0.44% | – |
BTZ | Exit | BlackRock Preferred and Equity Advantage | $0 | – | -73,392 | -100.0% | -0.54% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2017-08-14
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
TECHNOLOGY SELECT SECTOR SPDR FUND | 31 | Q3 2023 | 11.7% |
SELECT SECTOR SPDR TR | 28 | Q3 2023 | 9.1% |
Standard & Poor's Depositary Receipts | 28 | Q3 2023 | 8.2% |
ISHARES TRUST | 28 | Q1 2023 | 3.0% |
SELECT SECTOR SPDR TR | 26 | Q3 2023 | 8.8% |
ISHARES U.S. MEDICAL DEVICES ETF | 26 | Q3 2023 | 4.7% |
ISHARES TRUST | 25 | Q1 2023 | 8.8% |
SELECT SECTOR SPDR TR | 23 | Q3 2023 | 9.1% |
ISHARES TRUST | 22 | Q1 2023 | 2.3% |
SELECT SECTOR SPDR TR | 21 | Q2 2023 | 17.1% |
View Cavalier Investments, LLC's complete holdings history.
Latest filings
Type | Filed |
---|---|
13F-HR | 2024-04-26 |
13F-HR | 2024-02-13 |
13F-HR | 2023-10-23 |
13F-HR | 2023-08-11 |
13F-HR | 2023-05-10 |
13F-HR | 2023-02-10 |
13F-HR | 2022-11-10 |
13F-HR | 2022-08-04 |
13F-HR | 2022-05-04 |
13F-HR | 2022-02-02 |
View Cavalier Investments, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.